PloS oneHumansGranulocyte Colony-Stimulating FactorLeukemiaMyeloidAcute
Exploring innovative G-CSF schedules in AML cytarabine-based consolidation through a digital twin study of white blood cell recovery.
Adrian-Manuel Reimann, Enrico Schalk, Dimitrios Mougiakakos, Thomas Fischer, Sebastian Sager
Published: 202610.1371/journal.pone.0329242
Abstract
Patients with acute myeloid leukemia (AML) are at high risk for life-threatening infectious complications due to chemotherapy-induced leukopenia. In contrast to other malignancies, prophylactic administration of granulocyte colony-stimulating factors…
Preview only. Read the full abstract at the source